Annual CFI
$35.64 M
+$5.57 M+18.51%
31 December 2023
Summary:
Corbus Pharmaceuticals Holdings annual cash flow from investing activities is currently $35.64 million, with the most recent change of +$5.57 million (+18.51%) on 31 December 2023. During the last 3 years, it has risen by +$36.13 million (+7456.45%). CRBP annual CFI is now at all-time high.CRBP Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFI
-$15.37 M
+$1.07 M+6.53%
30 September 2024
Summary:
Corbus Pharmaceuticals Holdings quarterly cash flow from investing activities is currently -$15.37 million, with the most recent change of +$1.07 million (+6.53%) on 30 September 2024. Over the past year, it has dropped by -$26.26 million (-241.00%). CRBP quarterly CFI is now -135.76% below its all-time high of $42.96 million, reached on 31 March 2022.CRBP Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFI
-$119.65 M
-$26.26 M-28.12%
30 September 2024
Summary:
Corbus Pharmaceuticals Holdings TTM cash flow from investing activities is currently -$119.65 million, with the most recent change of -$26.26 million (-28.12%) on 30 September 2024. Over the past year, it has dropped by -$156.69 million (-423.09%). CRBP TTM CFI is now -423.09% below its all-time high of $37.03 million, reached on 30 September 2023.CRBP TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CRBP Cash From Investing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +18.5% | -241.0% | -423.1% |
| 3 y3 years | +7456.4% | -5508.3% | -70.5% |
| 5 y5 years | +1649.4% | -1186.6% | -6934.6% |
CRBP Cash From Investing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +148.6% | -135.8% | +84.4% | -423.1% | at low |
| 5 y | 5 years | at high | +148.6% | -135.8% | +84.4% | -423.1% | at low |
| alltime | all time | at high | +148.6% | -135.8% | +84.4% | -423.1% | at low |
Corbus Pharmaceuticals Holdings Cash From Investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$15.37 M(-6.5%) | -$119.65 M(+28.1%) |
| June 2024 | - | -$16.44 M(-83.3%) | -$93.39 M(+37.0%) |
| Mar 2024 | - | -$98.24 M(-1045.7%) | -$68.14 M(-291.2%) |
| Dec 2023 | $35.64 M(+18.5%) | $10.39 M(-4.7%) | $35.64 M(-3.8%) |
| Sept 2023 | - | $10.90 M(+23.7%) | $37.03 M(+83.6%) |
| June 2023 | - | $8.81 M(+58.7%) | $20.17 M(-374.8%) |
| Mar 2023 | - | $5.55 M(-52.9%) | -$7.34 M(-124.4%) |
| Dec 2022 | $30.07 M(-141.0%) | $11.78 M(-297.3%) | $30.07 M(+98.9%) |
| Sept 2022 | - | -$5.97 M(-68.1%) | $15.12 M(-29.3%) |
| June 2022 | - | -$18.70 M(-143.5%) | $21.37 M(-20.8%) |
| Mar 2022 | - | $42.96 M(-1452.1%) | $26.97 M(-136.7%) |
| Dec 2021 | -$73.42 M(>+9900.0%) | -$3.18 M(-1218.4%) | -$73.42 M(+4.6%) |
| Sept 2021 | - | $284.10 K(-102.2%) | -$70.19 M(-0.5%) |
| June 2021 | - | -$13.10 M(-77.2%) | -$70.53 M(+22.8%) |
| Mar 2021 | - | -$57.42 M(<-9900.0%) | -$57.45 M(>+9900.0%) |
| Dec 2020 | -$484.50 K(-82.3%) | $52.10 K(-191.7%) | -$484.50 K(-73.5%) |
| Sept 2020 | - | -$56.80 K(+250.6%) | -$1.83 M(-38.4%) |
| June 2020 | - | -$16.20 K(-96.5%) | -$2.97 M(-5.3%) |
| Mar 2020 | - | -$463.60 K(-64.1%) | -$3.13 M(+14.2%) |
| Dec 2019 | -$2.74 M | -$1.29 M(+8.1%) | -$2.74 M(+61.2%) |
| Sept 2019 | - | -$1.19 M(+551.5%) | -$1.70 M(+177.7%) |
| June 2019 | - | -$183.30 K(+149.0%) | -$612.50 K(-44.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2019 | - | -$73.60 K(-70.5%) | -$1.10 M(-52.0%) |
| Dec 2018 | -$2.30 M(+225.2%) | -$249.80 K(+136.1%) | -$2.30 M(-12.6%) |
| Sept 2018 | - | -$105.80 K(-84.3%) | -$2.63 M(+2.3%) |
| June 2018 | - | -$675.20 K(-46.8%) | -$2.57 M(+32.7%) |
| Mar 2018 | - | -$1.27 M(+118.8%) | -$1.94 M(+173.8%) |
| Dec 2017 | -$707.40 K(+100.4%) | -$580.20 K(+1178.0%) | -$707.40 K(+216.9%) |
| Sept 2017 | - | -$45.40 K(+8.9%) | -$223.20 K(-9.9%) |
| June 2017 | - | -$41.70 K(+4.0%) | -$247.70 K(-24.4%) |
| Mar 2017 | - | -$40.10 K(-58.2%) | -$327.80 K(-7.1%) |
| Dec 2016 | -$353.00 K(+209.6%) | -$96.00 K(+37.3%) | -$353.00 K(+0.9%) |
| Sept 2016 | - | -$69.90 K(-42.6%) | -$350.00 K(+22.9%) |
| June 2016 | - | -$121.80 K(+86.5%) | -$284.90 K(+60.4%) |
| Mar 2016 | - | -$65.30 K(-29.8%) | -$177.60 K(+55.8%) |
| Dec 2015 | -$114.00 K(+77.0%) | -$93.00 K(+1837.5%) | -$114.00 K(+442.9%) |
| Sept 2015 | - | -$4800.00(-66.9%) | -$21.00 K(-71.1%) |
| June 2015 | - | -$14.50 K(+752.9%) | -$72.60 K(+9.8%) |
| Mar 2015 | - | -$1700.00(<-9900.0%) | -$66.10 K(+2.6%) |
| Dec 2014 | -$64.40 K(<-9900.0%) | $0.00(-100.0%) | -$64.40 K(0.0%) |
| Sept 2014 | - | -$56.40 K(+605.0%) | -$64.40 K(+705.0%) |
| June 2014 | - | -$8000.00(<-9900.0%) | -$8000.00(<-9900.0%) |
| Mar 2014 | - | $0.00 | $0.00 |
| Dec 2013 | $0.00 | - | - |
FAQ
- What is Corbus Pharmaceuticals Holdings annual cash flow from investing activities?
- What is the all time high annual CFI for Corbus Pharmaceuticals Holdings?
- What is Corbus Pharmaceuticals Holdings annual CFI year-on-year change?
- What is Corbus Pharmaceuticals Holdings quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for Corbus Pharmaceuticals Holdings?
- What is Corbus Pharmaceuticals Holdings quarterly CFI year-on-year change?
- What is Corbus Pharmaceuticals Holdings TTM cash flow from investing activities?
- What is the all time high TTM CFI for Corbus Pharmaceuticals Holdings?
- What is Corbus Pharmaceuticals Holdings TTM CFI year-on-year change?
What is Corbus Pharmaceuticals Holdings annual cash flow from investing activities?
The current annual CFI of CRBP is $35.64 M
What is the all time high annual CFI for Corbus Pharmaceuticals Holdings?
Corbus Pharmaceuticals Holdings all-time high annual cash flow from investing activities is $35.64 M
What is Corbus Pharmaceuticals Holdings annual CFI year-on-year change?
Over the past year, CRBP annual cash flow from investing activities has changed by +$5.57 M (+18.51%)
What is Corbus Pharmaceuticals Holdings quarterly cash flow from investing activities?
The current quarterly CFI of CRBP is -$15.37 M
What is the all time high quarterly CFI for Corbus Pharmaceuticals Holdings?
Corbus Pharmaceuticals Holdings all-time high quarterly cash flow from investing activities is $42.96 M
What is Corbus Pharmaceuticals Holdings quarterly CFI year-on-year change?
Over the past year, CRBP quarterly cash flow from investing activities has changed by -$26.26 M (-241.00%)
What is Corbus Pharmaceuticals Holdings TTM cash flow from investing activities?
The current TTM CFI of CRBP is -$119.65 M
What is the all time high TTM CFI for Corbus Pharmaceuticals Holdings?
Corbus Pharmaceuticals Holdings all-time high TTM cash flow from investing activities is $37.03 M
What is Corbus Pharmaceuticals Holdings TTM CFI year-on-year change?
Over the past year, CRBP TTM cash flow from investing activities has changed by -$156.69 M (-423.09%)